Alife Health, an SF-based in vitro fertilization startup, raised $22 million in Series A funding co-led by Lux Capital, USV and Maveron, per Axios.
Alife Health Scores $22M in A Round
Related Posts
Healthtech Startup Eka Care Raises $15M
Hummingbird Ventures led the round.
Atlas Health Raises $40M Series A
Felicis Ventures led the round.
VSS Capital Partners Invests in Center for Rheumatology
Founded in 2008 and based in Los Angeles, CFR specializes in treating arthritis, rheumatoid arthritis, celiac disease, psoriasis, lupus, gout, and certain myofascial conditions.
Cypress Ridge Debuts with Cardiac Care Deal
Cardiology is the largest pocket of health care spend and the field is in desperate need of innovation.